Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection
Emily Lutterloh(Kentucky Department for Public Health), Noubar Kessimian(Memorial Hospital of Rhode Island), Brian M. Clancy(Women's Health Research Institute), Nicholas Parejo(Memorial Hospital of Rhode Island), Kim Milarski(Women's Health Research Institute), Ying Sun(Capital Medical University), Xiangyang Tan(Women's Health Research Institute), John E. Palardy(Brown University), James C. Keith(Women's Health Research Institute), Debra D. Pittman(Women's Health Research Institute), Helen Palmer(Women's Health Research Institute), Steven M. Opal(Brown University)
Cited by 166
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Intensive Care Medicine|2003|2.9k